能否用时差成像识别新型早期无创胚胎质量生物标志物以预测活产
该回顾性研究纳入2014年1月至2017年12月间ICSI周期单胚胎移植的232枚胚胎,评估35项形态学、形态动力学及形态计量学参数与活产的关系。多因素分析显示,原核并列时原核中央定位与活产几率增加约2倍相关(OR=2.20),2细胞期多核卵裂球存在与活产几率减半相关(OR=0.51),其余33项参数无显著关联。
要点
- 原核并列时原核中央定位与活产几率增加约2倍相关(OR=2.20)。
- 2细胞期多核卵裂球存在与活产几率减半相关(OR=0.51)。
- 其余33项形态学、形态动力学及形态计量学参数与活产无显著关联。
核心结论
- 在主要为高质量胚胎中,35项参数里仅原核并列时原核位置和2细胞期多核卵裂球缺失可能与活产相关。
研究设计与样本
- 回顾性研究,使用时差成像培养箱(EmbryoScope,Unisense FertiliTech),评估2014年1月至2017年12月间ICSI周期单胚胎移植后的232枚胚胎。
主要发现
- 原核中央定位与活产几率增加约2倍相关(OR=2.20;95%CI,[1.26-3.89];P=0.006)。
- 2细胞期多核卵裂球存在与活产几率减半相关(OR=0.51;95%CI,[0.27-0.95];P=0.035)。
- 这两个参数独立于胚胎动力学,其余33项参数与移植胚胎足月发育能力无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 即使人群规模相对较小,分析基于同质周期,即年轻女性其移植胚胎经传统形态学评估为高质量。
- 结论基于特定高度选择人群,其他研究人群如高龄女性可能得出不同结果。
- 因评估第2/3天移植,发现不能推广至培养至囊胚阶段的胚胎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can time-lapse imaging systems make it possible to identify novel early non-invasive biomarkers to predict live birth? SUMMARY ANSWER: From mostly high-grade embryos, out of 35 morphometric, morphologic and morphokinetic variables, only pronuclei (PN) position at time of PN juxtaposition and the absence of multinucleated blastomeres at the 2-cell stage (MNB2cell), were potentially associated with live birth. WHAT IS KNOWN ALREADY: Previous studies indicate that some kinetic markers may be predictive of blastocyst development and embryonic implantation. Certain teams have suggested including some of them in decisional algorithms for embryo transfers. STUDY DESIGN, SIZE, DURATION: Using a time-lapse incubator (EmbryoScope, Unisense FertiliTech), we retrospectively explored the associations between the morphometric, morphologic and morphokinetic parameters of oocytes, zygotes and embryos, and their associations with live birth. This study assessed 232 embryos from single embryo transfers after ICSI cycles performed between January 2014 and December 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: The morphometric, morphologic and morphokinetic parameters (18, 4 and 13, respectively) of oocytes, zygotes and early embryos were studied retrospectively. The associations between these parameters were examined using a Spearman's correlation, Mann-Whitney or chi-squared test as appropriate. We examined whether these parameters were associated with outcomes in univariate and multivariate logistic regression analyses. MAIN RESULTS AND THE ROLE OF CHANCE: Central PN juxtaposition was associated with a 2-fold increase in the odds of live birth (OR = 2.20; 95% CI, [1.26-3.89]; P = 0.006), while the presence of MNB2cell was associated with half the odds of live birth (OR = 0.51; 95% CI, [0.27-0.95]; P = 0.035). These two parameters were independent of embryo kinetics. The 33 remaining parameters had no significant association with the capacity of transferred embryos to develop to term. LIMITATIONS, REASONS FOR CAUTION: Even though the population size was relatively small, our analyses were based on homogeneous cycles, i.e. young women whose transferred embryos were found to be high-grade according to conventional morphology evaluation. In addition, our conclusions were established from a specific, highly selected population, so other study populations, such as women in an older age bracket, may yield different results. Finally, because we assessed day 2/3 transfers, our findings cannot be generalized to embryos cultured up to the blastocyst stage. WIDER IMPLICATIONS OF THE FINDINGS: It would be interesting to explore, prospectively, whether PN localisation is a relevant measure to predict embryo development when added into further algorithms and whether this parameter could be suitable for use in other IVF clinics. Further studies are needed, notably to explore the added value of timing evaluation in cohorts of embryos with low or intermediate morphology grade, as well as in other maternal populations (i.e. older women). STUDY FUNDING/COMPETING INTEREST(S): No external funding was used for this study. P. Sagot received funding from the following commercial companies: Merck Serono, Finox Biotech, Ferring, MSD France SAS, Teva Sante ́ SAS, Allergan France, Gedeon Richter France, Effik S.A., Karl Storz Endoscopie France, GE Medical Systems SCS, Laboratoires Genevrier, H.A.C. Pharma and Ipsen.All the authors confirm that none of this funding was used to support the research in this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the journal policies on sharing data and materials.
引用
- Barberet J, Bruno C, Valot E, et al. Can novel early non-invasive biomarkers of embryo quality be identified with time-lapse imaging to predict live birth? Hum Reprod. 2019. PMID: 31287145. doi:10.1093/humrep/dez085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。